Indeed, simulation of a decrease in the fraction of blood chlordecone binding to albumin (related to the observed lower plasma albumin concentration for patients with stage F4 liver fibrosis than those with no fibrosis) resulted in a decreased steady-state plasma chlordecone concentration. This evidence concerns the gene ALB and fibrosis.